PharmStars Fall 2026 Accelerator: Digital Innovations in Immunology
By PharmStars
Closed
Loading...
By PharmStars
StartupGrantsIndia
India's startup funding directory — grants, schemes, competition and perks in one place. We help startups and SMEs discover, evaluate, and win non-dilutive funding through grants, challenges, and government schemes. We don't just list opportunities—we help you understand eligibility, assess fit, track deadlines, and apply smarter. From discovery to submission, we make grant funding simpler and more accessible.
© 2026 NEXORA TECHNOLOGY. All rights reserved.
We are a private platform. Not affiliated with any government body.
Check your eligibility
Create a free account and we'll tell you whether your startup qualifies for this grant.
See if you're eligible
Full eligibility criteria — entity type, stage, sector, founder profile and registration requirements — plus your fit for this program. Create a free account to view.
PharmStars PharmStars is a specialized accelerator for pharmaceutical and healthcare startups, connecting innovators in drug discovery, medtech, digital health, and life sciences with industry mentors, investors, and pharma corporate partners. What Startups Receive Mentorship…
Learn more
Selection Process
Applications are rigorously reviewed by a specialized selection committee. This committee comprises PharmStars' experienced team of former pharma executives, who possess deep expertise in digital health, innovation, and startups, along with key representatives from their extensive pharma member network. The evaluation process prioritizes startups with market-ready solutions that demonstrate strong alignment with the "Digital Innovations in Immunology" theme and show significant potential for forging successful partnerships with pharmaceutical companies. Shortlisted startups may be invited for further discussions, presentations, or interviews to assess their fit and readiness for the accelerator. Final acceptance decisions are communicated by August 26, 2026.
Apply Online
Submit your application online for the Fall 2026 cohort by July 12, 2026, including details about your digital health solution.
You
Four steps from draft to disbursement — one action each.
Draft your application
Answer the form inside the grant tracker — AI drafts each response using your past answers, so you're not starting from a blank page.
Submit on the official portal
Use the official application link and verify all details before final submission.
Follow up
Reach out 5–7 days after submitting to confirm receipt and ask about the review timeline.
Data on this page is compiled from official program and provider references.
The Fall 2026 cohort focuses on "Digital Innovations in Immunology," covering disease prevention, diagnosis, treatment, and patient care for conditions related to the immune system. This includes improving patient identification, personalized treatment, disease monitoring, and enhancing drug development.
Startups receive pharma education through the PharmaU curriculum, personalized mentoring from experienced former pharma executives, direct access to pharmaceutical companies for partnership opportunities, and an investment from the PharmStars Ventures Fund.
The program is a 10-week virtual accelerator. Its online format allows for global participation, culminating in a virtual Startup Showcase where startups pitch their solutions to pharma members.
Quick Answer
A 10-week virtual accelerator offering pharma education, personalized mentoring, direct pharma access, and investment for digital health startups worldwide focusing on immunology.
Applications for this round closed on 12 July 2026. The organiser has not published a selection list that we can verify yet.
Selections for this programme are announced by PharmStars. Official links are listed under Sources below.
We update this page when results are published, and when the next round opens.
PharmStars is the leading pharma-focused accelerator dedicated to advancing digital health adoption to improve patient outcomes. This virtual 10-week program is specifically designed to bridge the gap between innovative digital health startups and established pharmaceutical and biotech firms, fostering successful collaborations. PharmStars achieves this through its unique PharmaU curriculum, which educates startups on the intricacies of drug development, pharma's organizational structures, business models, regulatory drivers, and deal structures.
The accelerator's mission is to facilitate and accelerate partnerships, leading to greater success for startups and faster integration of digital health solutions into patient care. With a proven track record of 10 successful cohorts, 112 graduated startups, and over $1 billion in cumulative funding raised by alumni, PharmStars offers an unparalleled opportunity for digital health innovators.
The Fall 2026 cohort theme, "Digital Innovations in Immunology," addresses the complex challenges within the immune system, which impacts hundreds of millions globally with conditions like autoimmune diseases, inflammatory conditions, allergies, and asthma. The program seeks startups developing digital solutions for immunological disease prevention, diagnosis, treatment, and patient care. This includes areas such as improving patient identification and diagnosis, enabling personalized treatment, monitoring disease progression, enhancing drug development and safety, and improving patient access and care coordination.
What You Get
The PharmStars Fall 2026 Accelerator offers an investment from the PharmStars Ventures Fund to selected digital health startups. Beyond funding, participants receive a comprehensive 10-week virtual program, featuring a specialized PharmaU curriculum on drug development, pharma structures, and deal negotiation. Startups benefit from personalized mentoring, direct access to pharma and biotech firms, and a Startup Showcase to present their solutions to key industry players, accelerating successful partnerships.
Yes, the PharmStars Fall 2026 Accelerator is a virtual program explicitly designed to be open to digital health startups from anywhere in the world, not limited by geographical location.
Applications for the Fall 2026 cohort are currently open and must be submitted by July 12, 2026. Accepted startups will be notified by August 26, 2026.
The program invites digital health startups with market-ready solutions, typically those with a product or prototype already developed, addressing any aspect of the "Digital Innovations in Immunology" theme. This implies product-stage or early revenue startups.
Higgsfield AI Credits — up to 36% off
Higgsfield Plus (1,200 credits per month) for 1 year. Official price ₹39,168 — SGI price ₹25,000. Leave your details and we call within one working day to complete payment.
Notion SaaS Credits — up to ₹5L
Rs. 5 Lakhs+ in Notion workspace credits — databases, wikis, project management, and team docs — for new users with a work email.
Semrush SaaS Credits
7-day free trial of Semrush Pro or Guru — full SEO, keyword research, competitive audit, and rank tracking across India and global SERPs.
